GNH USA

Europe — EMA

Metformina Odipe

GNH USA supplies Metformina Odipe (Metformin), a Biguanide oral antidiabetic for type 2 diabetes mellitus. Request a quote for global supply to your facility.

Metformin Hydrochloride

Request sourcing

1
Pack/s

What is Metformin Hydrochloride?

Metformin, the active ingredient in Metformina Odipe, is a Biguanide presented as a tablet for oral use. It lowers elevated blood glucose levels in adults with type 2 diabetes mellitus by improving insulin sensitivity and reducing hepatic glucose production.

GNH USA supplies Metformina Odipe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions. Customers benefit from reliable supply chains, competitive pricing, and responsive technical support.

What is Metformin Hydrochloride used for?

Metformina Odipe (metformin) is used to manage hyperglycemia in the type 2 diabetes pathway and related metabolic conditions. - Type 2 diabetes mellitus: improves glycemic control and reduces the risk of diabetes‑related complications. - Prediabetes (impaired fasting glucose): helps delay progression to overt type 2 diabetes when combined with lifestyle measures. - Polycystic ovary syndrome (PCOS): assists in restoring ovulatory function and reducing insulin resistance in affected women.

What are the side effects of Metformin Hydrochloride?

Metformina Odipe may cause a range of adverse reactions, most of which are related to the gastrointestinal system. Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Diarrhea: loose stools, especially after starting therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient metallic sensation in the mouth. Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Vitamin B12 deficiency: anemia and neuropathy with prolonged use.

What precautions apply to Metformin Hydrochloride?

Before initiating Metformina Odipe, clinicians should evaluate several safety considerations to minimize risk. - Renal function assessment: ensure adequate glomerular filtration rate before use. - Hepatic function monitoring: avoid in patients with significant liver disease. - Risk of lactic acidosis: contraindicated in conditions predisposing to hypoxia or severe infection. - Elderly patients: start at lower dose and monitor tolerance closely. - Vitamin B12 status: consider periodic testing during long‑term therapy. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

What does Metformin Hydrochloride interact with?

Metformina Odipe can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before and after imaging. - Cimetidine: can raise metformin plasma levels, increasing toxicity risk. - Alcohol excess: enhances lactic acidosis potential when combined with metformin. Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms, requiring closer glucose monitoring. - NSAIDs: can impair renal function and reduce metformin clearance.

Frequently asked questions

What is Metformina Odipe used for?+
Metformina Odipe contains metformin hydrochloride, an oral biguanide antidiabetic medication. It is prescribed primarily to improve blood‑glucose control in adults with type 2 diabetes mellitus. By lowering hepatic glucose output and increasing peripheral insulin sensitivity, it helps achieve target glycated hemoglobin levels when used together with diet and exercise. It may also be considered in pre‑diabetes or polycystic ovary syndrome under medical supervision.
How does metformin work?+
Metformin acts mainly by inhibiting mitochondrial complex I, which reduces hepatic gluconeogenesis and consequently lowers the amount of glucose released into the bloodstream. It also enhances insulin‑mediated glucose uptake in skeletal muscle and adipose tissue, and modestly decreases intestinal glucose absorption. Activation of AMP‑activated protein kinase (AMPK) contributes to these effects and supports improved lipid metabolism.
What is the usual dose of Metformina Odipe?+
The specific dose of Metformina Odipe is determined by the prescribing healthcare professional based on the patient’s renal function, glycemic targets, and tolerance. Typically, treatment starts with a low dose that is gradually increased to the effective maintenance dose. Patients should follow the prescriber’s instructions and not adjust the amount without medical advice.
Is Metformina Odipe safe during pregnancy or breastfeeding?+
Metformin crosses the placenta, and its safety in pregnancy is classified as category B in some regions, indicating that animal studies have not shown risk but adequate human data are lacking. It may be continued during pregnancy when the benefits outweigh potential risks, particularly in women with pre‑existing diabetes. Metformin is excreted in breast milk in small amounts; breastfeeding mothers should discuss continuation with their physician.
How do I order Metformina Odipe from GNH USA?+
To place an order, visit the product page on gnh-usa.com and submit an enquiry with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details—including any temperature‑controlled handling if needed—and assists with import documentation.
How does Metformina Odipe compare with other antidiabetic drugs?+
Compared with sulfonylureas, metformin does not stimulate insulin secretion, so it carries a lower risk of hypoglycemia. Unlike insulin, it is taken orally and does not require injection. In contrast to newer agents such as SGLT2 inhibitors, metformin is generally less expensive and has a long safety record, though it may cause gastrointestinal upset more frequently. Choice of therapy depends on individual patient characteristics and comorbidities.
What are the storage and handling requirements for Metformina Odipe?+
Metformina Odipe tablets should be stored at room temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged. No refrigeration is required, and the tablets remain stable for the shelf life indicated on the label when stored under these conditions.
How is Metformina Odipe administered?+
The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed. Dosing frequency (once or twice daily) is set by the prescriber based on the individual’s therapeutic response and tolerability. Consistent timing each day helps maintain stable blood‑glucose control.
What are the most serious risks associated with Metformina Odipe?+
The most critical adverse event is lactic acidosis, a rare but potentially fatal condition characterized by elevated blood lactate levels, especially in patients with renal impairment, hepatic disease, or severe infection. Severe skin reactions such as Stevens‑Johnson syndrome, and significant vitamin B12 deficiency leading to anemia or neuropathy with long‑term use, are also serious concerns. Prompt medical attention is required if symptoms such as unexplained fatigue, muscle pain, or skin blistering occur.
Who should not use Metformina Odipe?+
Metformina Odipe is contraindicated in individuals with known hypersensitivity to metformin or any component of the formulation, in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those receiving iodinated contrast studies without appropriate discontinuation. It should also be avoided in patients with severe liver disease or conditions predisposing to hypoxia. Clinicians must assess each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Metformin Hydrochloride
Route
Oral Use
Manufacturer
Pharmakern Portugal – Produtos Farmacêuticos, Sociedade Unipessoal, Lda.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU